BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 12663845)

  • 1. Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder.
    Miles H; Johnson S; Amponsah-Afuwape S; Finch E; Leese M; Thornicroft G
    Psychiatr Serv; 2003 Apr; 54(4):554-61. PubMed ID: 12663845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How does drug and alcohol misuse develop among people with psychotic illness? A literature review.
    Phillips P; Johnson S
    Soc Psychiatry Psychiatr Epidemiol; 2001 Jun; 36(6):269-76. PubMed ID: 11583456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample.
    Sara GE; Burgess PM; Malhi GS; Whiteford HA; Hall WC
    Aust N Z J Psychiatry; 2014 Nov; 48(11):1036-47. PubMed ID: 24819935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual diagnosis in the suburbs: prevalence, need, and in-patient service use.
    Wright S; Gournay K; Glorney E; Thornicroft G
    Soc Psychiatry Psychiatr Epidemiol; 2000 Jul; 35(7):297-304. PubMed ID: 11016524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotic symptoms, self-harm and violence in individuals with schizophrenia and substance misuse problems.
    Haddock G; Eisner E; Davies G; Coupe N; Barrowclough C
    Schizophr Res; 2013 Dec; 151(1-3):215-20. PubMed ID: 24268935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol and substance use by patients with psychosis presenting to an emergency department: changing patterns.
    Latt N; Jurd S; Tennant C; Lewis J; Macken L; Joseph A; Grochulski A; Long L
    Australas Psychiatry; 2011 Aug; 19(4):354-9. PubMed ID: 21851228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic meta-analysis of outcomes associated with psychosis and co-morbid substance use.
    Large M; Mullin K; Gupta P; Harris A; Nielssen O
    Aust N Z J Psychiatry; 2014 May; 48(5):418-32. PubMed ID: 24589980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Violence and self-harm in severe mental illness: inpatient study of associations with ethnicity, cannabis and alcohol.
    Dharmawardene V; Menkes DB
    Australas Psychiatry; 2017 Feb; 25(1):28-31. PubMed ID: 27679634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of substance misuse among individuals with severe mental illness in São Paulo.
    Rossi Menezes P; Ratto LR
    Soc Psychiatry Psychiatr Epidemiol; 2004 Mar; 39(3):212-7. PubMed ID: 14999454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of substance abuse treatment services by persons with mental health and substance use problems.
    Wu LT; Ringwalt CL; Williams CE
    Psychiatr Serv; 2003 Mar; 54(3):363-9. PubMed ID: 12610245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A national study of violent behavior in persons with schizophrenia.
    Swanson JW; Swartz MS; Van Dorn RA; Elbogen EB; Wagner HR; Rosenheck RA; Stroup TS; McEvoy JP; Lieberman JA
    Arch Gen Psychiatry; 2006 May; 63(5):490-9. PubMed ID: 16651506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulant use disorders: characteristics and comorbidity in an Australian population sample.
    Sara G; Burgess P; Harris M; Malhi GS; Whiteford H; Hall W
    Aust N Z J Psychiatry; 2012 Dec; 46(12):1173-81. PubMed ID: 22990432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.
    Thoma P; Daum I
    Psychiatry Clin Neurosci; 2013 Sep; 67(6):367-83. PubMed ID: 23890122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing violence in schizophrenia patients with and without comorbid substance-use disorders to community controls.
    Short T; Thomas S; Mullen P; Ogloff JR
    Acta Psychiatr Scand; 2013 Oct; 128(4):306-13. PubMed ID: 23379839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbid addiction and major mental illness in Europe: a narrative review.
    Carrà G; Bartoli F; Brambilla G; Crocamo C; Clerici M
    Subst Abus; 2015; 36(1):75-81. PubMed ID: 25222286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Violence and severe mental illness: the effects of substance abuse and nonadherence to medication.
    Swartz MS; Swanson JW; Hiday VA; Borum R; Wagner HR; Burns BJ
    Am J Psychiatry; 1998 Feb; 155(2):226-31. PubMed ID: 9464202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traumatic life events and PTSD among women with substance use disorders and schizophrenia.
    Gearon JS; Kaltman SI; Brown C; Bellack AS
    Psychiatr Serv; 2003 Apr; 54(4):523-8. PubMed ID: 12663840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.